Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome

H K G Garelius, William Thomas Johnston, Alexandra Gwen Smith, S Park, L de Swart, P Fenaux, A Symeonidis, G Sanz, J Cermak, R Stauder, L Malcovati, M. Mittelman, A A van de Loosdrecht, C J van Marrewijk, David Bowen, Simon Crouch, T J M de Witte, E Hellstrom-Lindberg